[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"protein-deregulation\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:protein-deregulation":45},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":4,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":44},"100385501",false,"NCT04299529","Urinary Proteomics Combined With Home Blood Pressure Telemonitoring for Health Care Reform","Urinary Proteomics Combined With Home Blood Pressure Telemonitoring for Health Care Reform: a Randomised Controlled Trial","UPRIGHT-HTM","Inclusion Criteria:\n\n* Patients must have at least three additional guideline-defined risk factors, preferably including hypertension, type 2 diabetes mellitus (T2DM), or both;\n* Patients should be willing patients to engage for the duration of the study in home blood pressure telemonitoring (1 reading per day);\n* Patients must have an email address and internet access via smartphone, tablet, or laptop or desktop computer;\n* Patients should comply with the study protocol during the run-in phase.\n\nExclusion Criteria:\n\n* Type 1 diabetes mellitus;\n* Absence of a practicable echocardiographic window;\n* Previous or concurrent severe cardiovascular or non-cardiovascular disease;\n* Cancer within 5 years of enrolment;\n* Suspected substance abuse;\n* Psychiatric illness;\n* Use of nephrotoxic drugs;\n* Particpation in another clinical study.","ALL","55 Years","75 Years",{"count":20,"type":21},1000,"ESTIMATED","INTERVENTIONAL",[24],"NA","UPRIGHT-HTM will compare risk stratification, treatment efficiency and health economic outcomes of a diagnostic approach based on home blood pressure telemonitoring combined with urinary proteomic profiling with home blood pressure telemonitoring alone",[27,28,29,30,31],"Protein Deregulation","Blood Pressure","Health Care Utilization","Cost Effectiveness","Patient Empowerment","NOT_YET_RECRUITING","2020-03-05",{"date":35,"type":36},"2020-03-06","ACTUAL",{"date":38,"type":21},"2020-04-01",{"date":40,"type":21},"2026-07-31",{"name":42,"class":43},"KU Leuven","OTHER",12,""]